Are pricey cancer drugs worth the cost? ASCO means to find out
26.03.2014 / Fierce Pharma
Public debate over high drug prices is one thing. But pushback from doctors is something else altogether. And when those doctors happen to be in charge at the American Society of Clinical Oncology, drugmakers might want to start worrying.